25 June 2019
NHS England has launched a public consultation on the proposed service specifications for children's cancer services in England. Read initial responses and find out how to submit your response by 4 August...
6 June 2019
Today, Leslie Hamilton and his working group have published their independent review into how the law on gross negligence manslaughter and culpable homicide are applied to medical practice. RCPCH President, Professor Russell Viner, responds.
29 April 2019
At the European Congress on Obesity, which is being held in Glasgow this week, research will be presented about the associations between childhood body size and the risk of renal cancer. Dr Max Davie, RCPCH Officer for Health Improvement, responds.
9 April 2019
Boys aged 12-13 in Northern Ireland are to be offered a vaccine to protect them against Human Papillomavirus (HPV) related cancers, the Department of Health has announced. RCPCH responds.
29 March 2019
Experts from 13 national bodies, including seven Royal Colleges, have joined forces to launch new practical guidance to support doctors and other health professionals around valproate use in women and girls in their reproductive years.
16 January 2019
This BPSU study hopes to improve our knowledge of the incidence, clinical presentation and management of FPIES as well as improve awareness of the condition among paediatricians.
6 December 2018
A new feature for our 2019 RCPCH Conference and exhibition, these talks will showcase the latest ideas and discoveries in child health.
12 November 2018
This will study incidence, early management and outcomes of babies born with Harlequin ichthyosis (HI) or collodion membrane (CM). These are rare genetic conditions characterised by thick, tight scaly skin and significant neonatal mortality.
7 November 2018
The study aims to determine the incidence of FAS in the UK and Ireland, investigate which services are accessed by babies and children affected by the condition and raise awareness about FAS among clinical practitioners.
1 October 2018
The Department of Health & Social Care has issued urgent guidance relating to supply disruption of Mylan EpiPens for all health care professionals who prescribe, dispense or administer adrenaline auto-injectors.